Viemed Healthcare Inc (NASDAQ:VMD) — Market Cap & Net Worth
Market Cap & Net Worth: Viemed Healthcare Inc (VMD)
Viemed Healthcare Inc (NASDAQ:VMD) has a market capitalization of $335.11 Million ($335.11 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14396 globally and #3422 in its home market, demonstrating a 2.17% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Viemed Healthcare Inc's stock price $8.95 by its total outstanding shares 38017907 (38.02 Million). Also see Viemed Healthcare Inc balance sheet assets for a full breakdown of the balance sheet.
Viemed Healthcare Inc Market Cap History: 2018 to 2026
Viemed Healthcare Inc's market capitalization history from 2018 to 2026. Data shows growth from $144.47 Million to $340.26 Million (20.28% CAGR). Also see how efficiently does Viemed Healthcare Inc generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
Viemed Healthcare Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.01% | #392 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1400 of 3165 |
Weight: Viemed Healthcare Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Viemed Healthcare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Viemed Healthcare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check VMD live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.36x
Viemed Healthcare Inc's market cap is 1.36 times its annual revenue
Latest Price to Earnings (P/E) Ratio
27.07x
Viemed Healthcare Inc's market cap is 27.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $144.47 Million | $65.27 Million | $10.18 Million | 2.21x | 14.20x |
| 2019 | $235.71 Million | $80.26 Million | $8.53 Million | 2.94x | 27.65x |
| 2020 | $295.02 Million | $131.31 Million | $31.53 Million | 2.25x | 9.36x |
| 2021 | $198.45 Million | $117.06 Million | $9.13 Million | 1.70x | 21.75x |
| 2022 | $287.42 Million | $138.83 Million | $6.22 Million | 2.07x | 46.19x |
| 2023 | $298.44 Million | $183.01 Million | $10.24 Million | 1.63x | 29.14x |
| 2024 | $304.90 Million | $224.26 Million | $11.27 Million | 1.36x | 27.07x |
Competitor Companies of VMD by Market Capitalization
Companies near Viemed Healthcare Inc in the global market cap rankings as of September 18, 2026. Review how tangible is Viemed Healthcare Inc's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Viemed Healthcare Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Viemed Healthcare Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Viemed Healthcare Inc's market cap moved from $144.47 Million to $ 340.26 Million, with a yearly change of 20.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $340.26 Million | +20.46% |
| 2025 | $282.47 Million | -7.36% |
| 2024 | $304.90 Million | +2.17% |
| 2023 | $298.44 Million | +3.84% |
| 2022 | $287.42 Million | +44.83% |
| 2021 | $198.45 Million | -32.73% |
| 2020 | $295.02 Million | +25.16% |
| 2019 | $235.71 Million | +63.16% |
| 2018 | $144.47 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Viemed Healthcare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $335.11 Million USD |
| MoneyControl | $335.11 Million USD |
| MarketWatch | $335.11 Million USD |
| marketcap.company | $335.11 Million USD |
| Reuters | $335.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive … Read more